The Predictive and Prognostic Value of Ykl-40 in Kras Wild Type Patients with Metastatic Colorectal Cancer Treated with Third-Line Cetuximab and Irinotecan

Karen-Lise Garm Spindler, B.V. Vittrup, I.C. Christensen, J. S. Schou, A.J. Jakobsen, Estrid Vilma Solyom Høgdall, Niels Pallisgaard, D. N. Nielsen, Helle Hjorth Johannesen, J. H. Johansen

Original languageEnglish
JournalAnnals of Oncology
Pages (from-to)I39-I39
Publication statusPublished - 2010

Cite this